global-in-vitro-diagnostics-applications-market-industry
Published

November 2016

Global In-Vitro Diagnostics for Cardiology, Neurology Therapeutics Growth, Trends and Forecasts (2016 - 2021)

Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license

The In-Vitro diagnostic market is valued as a USD 20.05 billion market in 2016 and is expected to become a USD 26.40 billion by 2021, growing at a CAGR of 5.66%

Global In-Vitro Diagnostics for Cardiology and Neurology Therapeutics Market- Market Dynamics

The report details several driving and restraining factors for the market. Some of them are listed below.

Drivers

  • Widespread healthcare awareness
  • Increased spending capabilities of people on healthcare
  • High demand for technologically advanced equipment for the early and precise diagnosis of various diseases
  • Increase in number of incidences of the diseases
  • Minimally invasive and point of care techniques for diagnosis
  • The technological advancements and new developments in the diagnostic industry
  • Growing and rapidly aging population

Restraints

  • Stringent regulatory policies by governments
  • Reimbursement issues
  • Lack of funds

The market is segmented into different categories on the basis of techniques, products, usability, applications, end user and geographically. The technique segment is divided into categories like molecular diagnostics, point of care diagnostics, immunoassay, and clinical chemistry. The products segmentation included instruments, reagents, and data management. The applications segment includes the fields of oncology, hematology, diabetes, cardiology, etc. The end-users are academics, hospitals, and laboratories.

The market analysis is available for the geographical areas of North America, Europe, APAC and Rest of the World.

Some of the key players in the market are:

  • Alere Inc.
  • Becton Dickinson & Company
  • Biomerieux
  • Danaher Corporation
  • Roche Diagnostics

Key Deliverables in the Study

  • Market analysis for the In-Vitro Diagnostics for Cardiology and Neurology Therapeutics market, with region-specific assessments and competition analysis on the global and regional scale.
  • Market definition along with the identification of key drivers and restraints.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their market share.
  • Identification and analysis of the macro and micro factors that affect the market on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
  • A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
  • Insights on the major countries/regions where this industry is blooming and to also identify the regions that are still untapped.
RELATED REPORTS

Confused about which report to get?

Download a full report to understand our capabilities
Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license
Our Clients Include View All

Looking to Customize Report?